Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2005
10/06/2005US20050221460 Novel genetic products from ashbya gossypii, associated with the structure of the cell wall or the cytoskeleton
10/06/2005US20050221445 Useful as agents that inhibit virus infection of cells
10/06/2005US20050221422 Novel galactose transferases, peptides thereof and nucleic acid encoding the same
10/06/2005US20050221420 Nogo receptor homologues and their use
10/06/2005US20050221395 Methods and products based on oligomerization of stress proteins
10/06/2005US20050221368 Methods for identifying RNA binding compounds
10/06/2005US20050221347 Inhibitors of binding between proteins and macromolecular ligands
10/06/2005US20050221346 May be used to detect the presence of a cancer or to evaluate the prognosis of a known disease
10/06/2005US20050221328 Inhibitors of inflammatory gene activity and cholesterol biosynthesis
10/06/2005US20050221303 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
10/06/2005US20050221272 Obtaining a cell that expresses a fusion protein containing a glutamine-rich polypeptide and a fluorescent polypeptide; exposing the cell to a compound; incubating the cell, measuring second fluorescence emission
10/06/2005US20050220958 Pasteurisation process for microbial cells and microbial oil
10/06/2005US20050220912 Anti-inflammatory composition for treating pelvic endometriosis
10/06/2005US20050220910 Xanifolia-Y and Xanifolia-Y1, comprising at least one sugar, a triterpene, such as Sapogenin, and at least one side chains at Carbon 21 and 22, such as Angeloyl groups; antiproliferatives, anticarcinogens; ovarian cancer; solvent extraction, purification by liquid chromatography
10/06/2005US20050220909 Composition for protection against superficial vasodilator flush syndrome
10/06/2005US20050220908 Anti-inflammatory compositions for multiple sclerosis
10/06/2005US20050220907 Implanted medical devices with anti-inflammatory coatings
10/06/2005US20050220906 Pharmaceutical composition for treating rheumatism and the preparation thereof
10/06/2005US20050220905 Tribulus terrestris, Turnera diffusa and Cinnamon cassia extracts in a precise weight ratio with Ginkgo biloba extract and a carrier or excipient; impotence, erectile dysfunction; reduced libido; frigidity; anorgasmia; side effect reduction; vasodilation; dopaminergic agents; phosphodiesterase inhibitor
10/06/2005US20050220900 Use of extracts containing phytoestrogen selectively modulating estrogen-receptor-beta
10/06/2005US20050220899 Use of cisplatin in combination with folic acid for increasing cisplatin efficacy
10/06/2005US20050220897 nutraceuticals comprising indium sulfate, caffeine, cocoa powders, ethyl cellulose, and mixtures of zinc oxide, copper oxide, magnesium oxide, potassium iodide, and selenium, chromium and manganese amino acid chelates
10/06/2005US20050220895 Use of gallium to treat inflammatory arthritis
10/06/2005US20050220894 Colostrum-based composition
10/06/2005US20050220888 Controlled release compositions and methods for using same
10/06/2005US20050220884 Free-flowing, powdery composition containing alpha-liponic acid (derivates)
10/06/2005US20050220882 Materials for medical implants and occlusive devices
10/06/2005US20050220881 Pharmaceutical composition
10/06/2005US20050220876 Methods and composition of extended delivery of water insoluble drugs
10/06/2005US20050220875 Sustained-release tablet formulation
10/06/2005US20050220870 administering mixtures of proton pump inhibitors and buffers, used for prophylaxis of gastrointestinal disorders
10/06/2005US20050220868 Policosanol composition and its use in treatment of hypercholesterolemia
10/06/2005US20050220866 Novel capsule formulations of etoposide for oral use
10/06/2005US20050220864 Pharmaceutical dosage forms having controlled release properties that contain a GABAB receptor agonist
10/06/2005US20050220862 Compositions with reduced hepatotoxicity
10/06/2005US20050220861 Colonic release compostion
10/06/2005US20050220860 Stabilized pure vitamin-C in powder to liquid form using multi-encapsulation method
10/06/2005US20050220859 Methods for treating illnesses of the tracheo-bronchial tract, especially chronic obstructive pulmonary disease (COPD)
10/06/2005US20050220857 Physiologically compatible, phospholipid-containing, stable and hard matrix
10/06/2005US20050220855 Matrix for administering ergoline compounds such as lisuride; restless leg syndrome; circadian rhythm disorders; Parkinson's disease
10/06/2005US20050220852 Adhesive patch containing tulobuterol
10/06/2005US20050220851 Matrix type patch containing bronchodilators
10/06/2005US20050220850 Topical anhydrous and ethanol-free ascomycin compositions
10/06/2005US20050220846 Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4) glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function
10/06/2005US20050220845 Foods and drinks having health benefits and method for adding health benefits to foods and drinks
10/06/2005US20050220844 Oral preventive/therapeutic agent for skin damage containing diacylglyceryl ether
10/06/2005US20050220836 Drug delivery device
10/06/2005US20050220830 Composition of 20% BIT, 70% Polyethylene glycol, 2.1% NaOH and 7.9% water; microbiocide for latex, paint, coating, cosmetic or personal care formulations
10/06/2005US20050220827 Chloasma amelioration composition and dullness amelioration composition
10/06/2005US20050220823 Ophthalmic composition comprising ascomycin
10/06/2005US20050220819 Novel binding epitopes for helicobacter pylori and use thereof
10/06/2005US20050220804 Increasing an immune response in an animal, comprising administering a compound (such as a carbohydrate, an antibiotic, a sugar, a protein, or an antibody) that binds a C-type lectin (but not the DEC-205 receptor) on the surface of a dendritic cell
10/06/2005US20050220802 Vaccine and method for treatment of motor neurone diseases
10/06/2005US20050220799 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
10/06/2005US20050220791 Novel of cytokine inhibitors
10/06/2005US20050220784 Quinazoline derivatives as medicaments
10/06/2005US20050220779 Exert antiinflammatory effect by inhibiting inducible nitric oxide synthaseiand cyclooxygenase-2 expression, at level of transcription by suppressing activation of nuclear factor kappa B; cell-free assay
10/06/2005US20050220768 Materials and methods for treating ocular-related disorders
10/06/2005US20050220763 Method of treating idiopathic pulmonary fibrosis with aerosolized IFN-gamma
10/06/2005US20050220756 Nitrosation of a organosulfur polymer; coating medical equipment such as tubes, catheters
10/06/2005US20050220755 Topical composition based on ion-exchange resins, in particular for treating erythemas
10/06/2005US20050220753 Hydrophilic polymers-flavoids conjugates and pharmaceutical compositions comprising them
10/06/2005US20050220752 removing potassium from the gastrointestinal tract with a potassium-binding polymer; an alpha-fluoroacrylic acid polymer, or a difluoromaleic acid polymer crosslinked with vinylsulfonic acid, acrylic acid, vinyl phosphonate, vinyl-1,1-bisphosphonate, vinyl sulfonate, vinyl-1,2-disulfonate, itaconic aci
10/06/2005US20050220751 Ion binding polymers and uses thereof
10/06/2005US20050220750 Methods and compositions for treatment of ion imbalances
10/06/2005US20050220742 Compositions and methods for maintaining eyelid hygiene
10/06/2005US20050220726 Use of sugar esters in cosmetic and/or pharmaceutical preparations
10/06/2005US20050220718 Stable pharmaceutical solution formulations for pressurized metered dose inhalers
10/06/2005US20050220717 Steroid solution aerosol products with enhanced chemical stability
10/06/2005US20050220716 Drug delivery assembly
10/06/2005US20050220715 Methods and compositions for improving drug safety
10/06/2005US20050220707 piperazine(piperidine)carboxamidine; antidepressant, brain trauma, ischemia, stroke, neurodegenerative disorders, opioid addiction, idiopathic pain, epilepsy; varying activities on nitric oxide synthases (NOS), arginine decarboxylases (ADC), and nitrosodimethylamine (NDMA) receptor binding
10/06/2005US20050220705 Methods for treating non-melanoma cancers with PABA
10/06/2005DE20320991U1 Use of palonosetron in the treatment and prevention of chemotherapy and radiotherapy-induced acute and delayed emesis
10/06/2005DE20221386U1 Use of 1,2-alkanediol mixture as an antimicrobial agent, e.g. for treating body odor, acne or mycoses or preserving perishable products
10/06/2005DE20122435U1 Mikronisiertes Zolpidem-Hemitartrat Micronized zolpidem hemitartrate
10/06/2005DE102004014296A1 Substituierte 1,4,8-Triazaspiro[4.5]decan-2-on-Verbindingen Substituted 1,4,8-triazaspiro [4.5] decan-2-one Verbindingen
10/06/2005DE102004012676A1 New glucopyranosyl-substituted benzene derivatives are sodium-dependent glucose cotransporter inhibitors, useful for treating e.g. metabolic disorders (type 1 and type 2 diabetes mellitus or metabolic acidosis)
10/06/2005CA2666359A1 Process for the production of atorvastatin calcium in amorphous form
10/06/2005CA2627940A1 Process for the production of atorvastatin calcium in amorphous form
10/06/2005CA2610628A1 Combination therapy
10/06/2005CA2609972A1 Method and compositions for treatment of chronic neuropathic pain
10/06/2005CA2599543A1 Oral health care drink and method for reducing malodors
10/06/2005CA2599345A1 Antimicrobial composition for pre-harvest and post-harvest treatment of plants and animals
10/06/2005CA2563164A1 Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists
10/06/2005CA2562633A1 Thyroid receptor agonists
10/06/2005CA2561696A1 Novel modified galectin 9 proteins and use thereof
10/06/2005CA2561639A1 Novel urea derivatives and their medical use
10/06/2005CA2561488A1 Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonists
10/06/2005CA2561117A1 Decoy nucleic acid to synoviolin gene promoter
10/06/2005CA2561066A1 Antiviral 4-aminocarbonylamino-substituted imidazole compounds
10/06/2005CA2561059A1 Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin
10/06/2005CA2561057A1 Prolinyl derivatives for treating thrombosis
10/06/2005CA2560988A1 Use of a phenothiazine derivative for preventing and/or treating hearing loss
10/06/2005CA2560931A1 Novel cyclopentenedione antifungal compounds and methods for their use
10/06/2005CA2560928A1 Therapeutic agent for diabetes containing insulin resistance improving agent
10/06/2005CA2560927A1 Insulin resistance-improving agent
10/06/2005CA2560923A1 Annexin ii and uses thereof
10/06/2005CA2560922A1 Improvements in or relating to compounds for use in the treatment of aids and other viral diseases and hiv-related infections and compositions containing such compounds, methods of treating such diseases and infections and methods of making such compounds and compositions
10/06/2005CA2560920A1 Use of a serine palmitoyltransferase (spt) inhibitor to treat atherosclerosis and dyslipidemia
1 ... 4516 4517 4518 4519 4520 4521 4522 4523 4524 4525 4526 4527 4528 4529 4530 4531 4532 4533 4534 4535 4536 ... 7860